These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8169427)

  • 1. Prevalence and epidemiologic correlates of human T cell lymphotropic virus infection among intravenous drug users.
    Schwebke J; Calsyn D; Shriver K; Saxon A; Kleyn J; Oluoch-Mitchell E; Olmstead L; Fisher LD; Krone M; Ashley R
    J Infect Dis; 1994 May; 169(5):962-7. PubMed ID: 8169427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?
    Khabbaz RF; Hartel D; Lairmore M; Horsburgh CR; Schoenbaum EE; Roberts B; Hartley TM; Friedland G
    J Infect Dis; 1991 Feb; 163(2):252-6. PubMed ID: 1988509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity.
    Feigal E; Murphy E; Vranizan K; Bacchetti P; Chaisson R; Drummond JE; Blattner W; McGrath M; Greenspan J; Moss A
    J Infect Dis; 1991 Jul; 164(1):36-42. PubMed ID: 2056217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of HTLV types I and II among drug users in King County, Washington.
    Thiede H; Harris NV; McGough JP; Roberts B; Khabbaz RF; Kaplan JE
    West J Med; 1994 Jun; 160(6):540-4. PubMed ID: 8053176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
    J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV infections among Swedish intravenous drug users in 1992.
    Andersson S; Krook A; Käll K; Julander I; Thorstensson R; Biberfeld G
    Scand J Infect Dis; 1995; 27(6):547-50. PubMed ID: 8685631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994.
    Krook A; Albert J; Andersson S; Biberfeld G; Blomberg J; Eklund I; Engström A; Julander I; Käll K; Martin C; Stendahl P; Struve J; Sönnerborg A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Aug; 15(5):381-6. PubMed ID: 9342259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroepidemiology of viral infections among intravenous drug users in northern California.
    Zeldis JB; Jain S; Kuramoto IK; Richards C; Sazama K; Samuels S; Holland PV; Flynn N
    West J Med; 1992 Jan; 156(1):30-5. PubMed ID: 1310362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T-cell lymphotrophic virus in California's injection drug users.
    Trachtenberg AI; Gaudino JA; Hanson CV
    J Psychoactive Drugs; 1991; 23(2):225-32. PubMed ID: 1765894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases.
    Giuliani M; Rezza G; Lepri AC; Di Carlo A; Maini A; Crescimbeni E; Palamara G; Prignano G; Caprilli F
    Sex Transm Dis; 2000 Feb; 27(2):87-92. PubMed ID: 10676975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infection among Spanish drug users measured by HTLV-1 assay and HTLV-1 and -2 assay. HTLV-1 and HTLV-2 Spanish Study Group.
    Henrard DR; Soriano V; Robertson E; Gutierrez M; Stephens J; Dronda F; Miles F; Pujol E; Buytendorp M; Castro A
    J Clin Microbiol; 1995 Jul; 33(7):1735-8. PubMed ID: 7665638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of human T cell lymphotropic virus types 1 and 2 (HTLV-1/2) in selected Tijuana subpopulations.
    Guerena-Burgueno F; Benenson AS; Sepulveda-Amor J; Ascher MS; Vugia DJ; Gallo D
    Am J Trop Med Hyg; 1992 Aug; 47(2):127-32. PubMed ID: 1503181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-2 infection in injection drug users in King County, Washington.
    Zunt JR; Tapia K; Thiede H; Lee R; Hagan H
    Scand J Infect Dis; 2006; 38(8):654-63. PubMed ID: 16857611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.
    Brown LS; Chu A; Allain JP; Lee H; Cerney M; Nemoto T
    N Y State J Med; 1991 Mar; 91(3):93-7. PubMed ID: 2047026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-1/2 among high-risk groups in Argentina: molecular diagnosis and prevalence of different sexual transmitted infections.
    Berini CA; Pando MA; Bautista CT; Eirin ME; Martinez-Peralta L; Weissenbacher M; Avila MM; Biglione MM
    J Med Virol; 2007 Dec; 79(12):1914-20. PubMed ID: 17935172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTLV-1 and HTLV-2 infections in HIV-infected individuals from Santos, Brazil: seroprevalence and risk factors.
    Etzel A; Shibata GY; Rozman M; Jorge ML; Damas CD; Segurado AA
    J Acquir Immune Defic Syndr; 2001 Feb; 26(2):185-90. PubMed ID: 11242188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low prevalence of human T-cell leukaemia virus-I and -II infection among drug users in Amsterdam, The Netherlands.
    van den Hoek JA; Al EJ; Huisman JG; Goudsmit J; Coutinho RA
    J Med Virol; 1991 Jun; 34(2):100-3. PubMed ID: 1890409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans.
    Wiktor SZ; Cannon RO; Atkinson WL; Lutz B; Hook EW; Blattner WA; Quinn TC
    J Infect Dis; 1992 May; 165(5):920-4. PubMed ID: 1569344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence and risk factors for human T cell lymphotropic virus type 1 and 2 infection in human immunodeficiency virus-infected patients attending AIDS referral center health units in Londrina and other communities in Paraná, Brazil.
    Morimoto HK; Caterino-De-Araujo A; Morimoto AA; Reiche EM; Ueda LT; Matsuo T; Stegmann JW; Reiche FV
    AIDS Res Hum Retroviruses; 2005 Apr; 21(4):256-62. PubMed ID: 15943567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of HTLV-I/II and HIV-1 among intravenous drug users in Detroit.
    Ognjan AF; Lewandowski CA; Belian BT; Burczak J; Markowitz N; Lee H; Saravolatz LD
    Henry Ford Hosp Med J; 1992; 40(1-2):131-5. PubMed ID: 1428966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.